Predicting Dropout and Outcome From Neuropsychological Functions in SUD Patients

This project collects the neuropsychological profile of residential SUD patients, in addition to treatment length, exit reason, hospital journal data and post-treatment clinical outcome data. The project aims to identify clinically relevant neurocognitive domains that predict treatment dropout and post-treatment clinical outcome. This will make it possible for future clinicians to focus their effort on neurocognitive functions most relevant for this particular patient group.

RESEARCH QUESTIONS:

• What neurocognitive domain (and sub-domain) are the strongest predictor of treatment drop-out and retention?
• What neurocognitive domain (and sub-domain) are the strongest predictor of post-treatment clinical outcome variables such as drug use, health and social integration.
• Will data on treatment length, age, gender, substance abuse history or psychiatric co-morbidity predict outcome independently, or in interaction with, the neuropsychological profile?

This longitudinal prospective cohort study aims for a continuous collection of neuropsychological data baseline and post-treatment follow-up data until 2030.

Inclusion criteria

• Substance Use Disorder (SUD) patients.
• 18 years or older.
• Qualified to consent to research participation.
• Able to speak and write in Norwegian.

Exclusion criteria

• Not qualified to consent to research participation.
• Insufficient understanding of Norwegian.